This federal contract award is for the delivery of BIOLOGICS - SYNTHETICS-MASTERGRAFT STRIP medical devices, valued at $6,720.30, by Medtronic Inc. through its Medtronic USA, Inc. division. The contract was awarded by the Defense Health Agency (DHA), a component of the Department of Defense, and does not have a set-aside designation.
Medtronic is a global leader in medical technology, specializing in innovative medical devices and therapies. The company has a significant Indefinite Delivery...
The U.S. government agency, the Defense Health Agency (DHA), awarded a $1,516.20 fixed-price with economic price adjustment delivery order contract to Medtronic Inc., through its Medtronic USA, Inc. division, to provide biologics - DBM-TS-GRAFTON DBF. This contract has an ultimate completion date of October 15, 2024. Medtronic is a global medical technology company that specializes in developing and manufacturing innovative medical devices and therapies. The company has a significant...
This is a federal delivery order awarded by the Defense Health Agency (DHA) to Medtronic Inc., through its Medtronic USA, Inc. division, for the supply of biologics and synthetic medical products. The $13,239.20 fixed-price with economic price adjustment contract has a period of performance through June 20, 2024. Medtronic is a global medical technology company that specializes in developing and manufacturing a wide range of innovative medical devices and therapies for federal agencies. The...
This is a federal contract award from the Defense Health Agency (DHA) to Medtronic Inc., through its Medtronic USA, Inc. division, for the delivery of BIOLOGICS - DBM-TS-MAGNIFUSE DBM medical devices. The contract is a Delivery Order with a fixed price and economic price adjustment, has a ceiling value of $14,820.00, and has a completion date of September 6, 2024. The contract is not designated as a set-aside. Medtronic, a global leader in medical technology, has a significant Indefinite...
This federal contract award was issued by the Defense Health Agency (DHA), a component of the Department of Defense (DoD), to Medtronic Inc. through its Medtronic USA, Inc. division. The $8,181.40 fixed-price delivery order contract is for the supply of BIOLOGICS - SYNTHETICS-MASTERGRAFT STRIP medical products. Medtronic is a global leader in medical technology and has been awarded numerous federal contracts and grants to provide a wide range of innovative medical devices and therapies to the...
This is a firm fixed-price delivery order awarded by the Defense Health Agency (DHA) to Medtronic Inc., through its Medtronic USA, Inc. division, for the procurement of various medical supplies and equipment. The contract, valued at $19,060.80, does not have a set-aside designation and covers the delivery of biologics, including Grafton DBF bone graft products, with a final delivery date of September 6, 2024. Medtronic is a global leader in medical technology and a major supplier to the...
This federal contract award, with an ID of SPE2DE21D7001|SPE2D624F3MB2, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Medtronic Inc., a global leader in medical technology. The $10,081.40 Delivery Order is for the procurement of BIOLOGICS - SYNTHETICS-MASTERGRAFT STRIP, with a fixed price and economic price adjustment pricing type. The contract has a period of performance through July 16, 2024 and does not utilize a set-aside designation. Medtronic,...
The U.S. government has awarded a $5,702.85 fixed-price delivery order contract to Medtronic Inc., through its Medtronic USA, Inc. division, for the supply of Biologics - DBM-TS-OTI Grafton DBM Matrix medical products. This contract was awarded by the Defense Health Agency (DHA), a component of the Department of Defense (DoD) that oversees the Military Health System. The contract has an ultimate completion date of December 9, 2024 and does not have a set-aside designation. Medtronic is a...
The Defense Logistics Agency Troop Support Medical has awarded a fixed-price delivery order contract to Medtronic Inc., a global medical technology company, to provide Biologics - Synthetics-Mastergraft Strip medical supplies valued at $11,087.92. The contract has a period of performance ending on March 7, 2024. Medtronic Inc., through its Medtronic USA, Inc. division, is a foreign-owned, for-profit manufacturer that has a history of supplying a wide range of medical devices and equipment to...
The U.S. government has awarded a $3,790.50 fixed-price delivery order contract to Medtronic Inc., through its Medtronic USA, Inc. division, for the supply of BIOLOGICS - DBM-TS-GRAFTON DBF medical products. This contract was issued by the Defense Health Agency (DHA), a component of the Department of Defense. The contract has no set-aside designation and runs through July 10, 2024. Medtronic is a global leader in medical technology, providing a wide range of innovative medical devices and...